cancer clinical trials in oklahoma city, OK
University of Oklahoma Health Sciences Center
Trial Locations University of Oklahoma Health Sciences Center Plaza Medical Group, Pc Oklahoma Heart Hospital Physicians Cor Clinical Research, Llc Eminence Research, Llc South Oklahoma Heart Research Atrial Fibrillation, Atrial Flutter
|
Cancer Specialists of Oklahoma
Oklahoma City, Oklahoma 73112 Prostate Cancer
|
South Oklahoma Heart Research
Oklahoma City, Oklahoma 73135 Venous Thrombosis, Pulmonary Embolism
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
Sooner Clinical Research
Trial Locations Sooner Clinical Research Oklahoma Foundation for Digestive Research Irritable Bowel Syndrome
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Leukemia
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Cervical Cancer
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
University of Oklahoma Health Science Center
Oklahoma City, Oklahoma 73104 Non-Hodgkin's Lymphoma
|
University of Oklahoma
Oklahoma City, Oklahoma 73190 Acute Myeloid Leukemia
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Sarcoma
|
Oklahoma University Health Science Center
Oklahoma City, Oklahoma 73104 Ovarian Cancer, Peritoneal Neoplasms
|
MS Center of Oklahoma
Oklahoma City, Oklahoma Multiple Sclerosis, Relapsing-Remitting
|
Health Research Of Oklahoma
Oklahoma City, Oklahoma 73103 Psoriatic Arthritis
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Leukemia
|
MS Center of Oklahoma, Mercy Health Center
Oklahoma City, Oklahoma Multiple Sclerosis, Relapsing-Remitting
|
GSK Investigational Site
Oklahoma City, Oklahoma 73112 Advanced Non-Small Cell Lung Cancer, Lung Cancer, Non-Small Cell
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Pancreatic Cancer
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Cervical Cancer, Endometrial Cancer, Lymphedema, Vulvar Cancer
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Hematological Neoplasms, Hematopoietic Stem Cell Transplantation
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Hearing Loss
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Breast Neoplasms
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Mucositis, Head and Neck Cancer
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Metastatic Breast Cancer
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Xerostomia
|
University of Oklahoma Health Science Center
Oklahoma City, Oklahoma 73104 Severe Sepsis
|
Site Reference ID/Investigator# 75279
Oklahoma City, Oklahoma 73104 Ovarian Cancer, Primary Peritoneal Cancer
|
University of Oklahoma Health Science Center
Oklahoma City, Oklahoma 73104 Non-Small Cell Lung Cancer
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myelomonocytic Leukemia (M4), Childhood Acute Basophilic Leukemia, Childhood Acute Eosinophilic Leukemia, Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
|
Oklahoma Gynecologic Oncology Group
Oklahoma City, Oklahoma 73112 Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Uterine Neoplasms, Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Cervical Cancer
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Unspecified Childhood Solid Tumor, Protocol Specific
|
Cancer Care Associates-Oklahoma City
Oklahoma City, Oklahoma 73112 Extensive-stage Small Cell Lung Cancer
|
University of Oklahoma
Oklahoma City, Oklahoma 73190 Breast Cancer, Osteoporosis
|
Cancer Specialists of Oklahoma
Oklahoma City, Oklahoma 73112 Advanced Cancer
|
The University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Myelodysplastic Syndrome (MDS)
|
The University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Non-small Cell Lung Cancer
|
GSK Investigational Site
Oklahoma City, Oklahoma 73112 Neoplasms, Breast
|
Oklahoma Oncology and Hematology, PC
Oklahoma City, Oklahoma 73112 Relapsed Follicular Lymphoma
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Head and Neck Cancer
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Sarcoma
|
Investigational Site Number
Oklahoma City, Oklahoma 73104 Cancer, Non-Small Cell Lung Cancer, Endometrial Carcinoma, Ovarian Carcinoma
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Brain Tumor
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Non-Hodgkin's Lymphoma
|
Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma 73104 Rheumatoid Arthritis
|
University of Oklahoma Health Sciences Center
Trial Locations University of Oklahoma Health Sciences Center Integris Baptist Medical Center Thrombotic Thrombocytopenic Purpura
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Chemotherapeutic Agent Toxicity, Endometrial Cancer, Fallopian Tube Cancer, Gastrointestinal Complications, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Endometrial Cancer
|
University of Oklahoma
Oklahoma City, Oklahoma 73190 Transfusional Hemosiderosis
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Head and Neck Cancer
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Leukemia
|
OU Cancer Institute
Oklahoma City, Oklahoma 73104 Uterine Cervical Cancer, Endometrial Cancer
|
VA Medical Center
Oklahoma City, Oklahoma 73104 Hemoptysis
|
Oklahoma University Cancer Institute
Oklahoma City, Oklahoma 73104 Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
University of Oklahoma
Oklahoma City, Oklahoma 73190 Ovarian Cancer
|
University of Oklahoma Cancer Center
Oklahoma City, Oklahoma 73104 Primary Refractory Neuroblastoma
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Adnexal Mass, Ovarian Cancer
|
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma 73104 Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
|
OU Medical Center
Oklahoma City, Oklahoma 73104 Breast Cancer
|
Investigational Site Number 1434
Oklahoma City, Oklahoma 73084 Endometrial Cancer, Endometrial Neoplasms
|